Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19

2020; American Medical Association; Volume: 324; Issue: 13 Linguagem: Inglês

10.1001/jama.2020.16761

ISSN

1538-3598

Autores

Pierre‐François Dequin, Nicholas Heming, Ferhat Meziani, Gaëtan Plantefève, Guillaume Voiriot, Julio Badié, Bruno François, Cécile Aubron, Jean-Damien Ricard, Stéphan Ehrmann, Youenn Jouan, Antoine Guillon, M Leclerc, Carine Coffre, Hélène Bourgoin, Céline Lengellé, Caroline Caille-Fénérol, Elsa Tavernier, Sarah Zohar, Bruno Giraudeau, Djillali Annane, Amélie Le Gouge,

Tópico(s)

Sepsis Diagnosis and Treatment

Resumo

Coronavirus disease 2019 (COVID-19) is associated with severe lung damage. Corticosteroids are a possible therapeutic option.

Referência(s)